Pathogen inactivation in cellular blood components: Clinical trials and implications of introduction to transfusion medicine

被引:15
作者
AuBuchon, JP [1 ]
机构
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
关键词
D O I
10.1111/j.1423-0410.2002.tb05316.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:271 / 275
页数:5
相关论文
共 24 条
[21]  
van Rhenen D, 2000, BLOOD, V96, p819A
[22]   Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats [J].
van Rhenen, DJ ;
Vermeij, J ;
Mayaudon, V ;
Hind, C ;
Lin, D ;
Corash, L .
VOX SANGUINIS, 2000, 79 (04) :206-214
[23]  
Wages DS, 2001, BLOOD, V98, p449A
[24]   Fundamentals of the psoralen-based Helinx™ technology for inactivation of infectious pathogens and leukocytes in platelets and plasma [J].
Wollowitz, S .
SEMINARS IN HEMATOLOGY, 2001, 38 (04) :4-11